The Novo Nordisk Foundation and the Broad Institute of MIT and Harvard have launched the Novo Nordisk Foundation Center for Genomic Mechanisms of Disease, an initiative that aims to accelerate efforts to mine genetic data for insights into disease mechanisms—and eventually rationally designed treatments.   Based at the Broad Institute in Cambridge, MA, and supported by a grant of up to $47.5 million from the Foundation, the Center will generate systematic datasets that will help researchers ar...